Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)
Public ClinicalTrials.gov record NCT00095238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn if Irbesartan is superior to placebo in reducing mortality and cardiovascular morbidity in subjects with heart failure with preserved systolic function. The safety of this treatment will also be studied.
Study identification
- NCT ID
- NCT00095238
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 4,128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2002
- Primary completion
- Jun 30, 2008
- Completion
- Jun 30, 2008
- Last update posted
- Apr 6, 2015
2002 – 2008
United States locations
- U.S. sites
- 60
- U.S. states
- 32
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Birmingham | Alabama | — | — |
| Local Institution | Peoria | Arizona | — | — |
| Local Institution | Tucson | Arizona | — | — |
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Los Angeles | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | San Francisco | California | — | — |
| Local Institution | Farmington | Connecticut | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Jacksonville Beach | Florida | — | — |
| Local Institution | Lake Worth | Florida | — | — |
| Local Institution | Tampa | Florida | — | — |
| Local Institution | Vero Beach | Florida | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Peoria | Illinois | — | — |
| Local Institution | Jeffersonville | Indiana | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Chalmette | Louisiana | — | — |
| Local Institution | Shreveport | Louisiana | — | — |
| Local Institution | Auburn | Maine | — | — |
| Local Institution | Takoma Park | Maryland | — | — |
| Local Institution | Towson | Maryland | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Haverhill | Massachusetts | — | — |
| Local Institution | Natick | Massachusetts | — | — |
| Local Institution | Detroit | Michigan | — | — |
| Local Institution | Petoskey | Michigan | — | — |
| Local Institution | Minneapolis | Minnesota | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | Omaha | Nebraska | — | — |
| Local Institution | Reno | Nevada | — | — |
| Local Institution | Lebanon | New Hampshire | — | — |
| Local Institution | Elmer | New Jersey | — | — |
| Local Institution | Albuquerque | New Mexico | — | — |
| Local Institution | Albany | New York | — | — |
| Local Institution | East Syracuse | New York | — | — |
| Local Institution | Flushing | New York | — | — |
| Local Institution | Rochester | New York | — | — |
| Local Institution | The Bronx | New York | — | — |
| Local Institution | Troy | New York | — | — |
| Local Institution | Chapel Hill | North Carolina | — | — |
| Local Institution | Concord | North Carolina | — | — |
| Local Institution | Durham | North Carolina | — | — |
| Local Institution | Winston-Salem | North Carolina | — | — |
| Local Institution | Canton | Ohio | — | — |
| Local Institution | Cincinnati | Ohio | — | — |
| Local Institution | Columbus | Ohio | — | — |
| Local Institution | Lorain | Ohio | — | — |
| Local Institution | Sandusky | Ohio | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Flourtown | Pennsylvania | — | — |
| Local Institution | Lancaster | Pennsylvania | — | — |
| Local Institution | Charleston | South Carolina | — | — |
| Local Institution | Germantown | Tennessee | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Lynchberg | Virginia | — | — |
| Local Institution | Richmond | Virginia | — | — |
| Local Institution | South Boston | Virginia | — | — |
| Local Institution | Spokane | Washington | — | — |
| Local Institution | Madison | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 169 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00095238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00095238 live on ClinicalTrials.gov.